Cardiac Amyloidosis in Autopsy Case of Sudden Unexpected Death
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
A 78-year-old woman with a medical history of hypertension and diabetes mellitus who underwent surgery for lumbar stenosis died of sudden cardiac arrest two days after the operation. An autopsy was performed; however, the cause of death was not identified macroscopically. Congo red staining detected amyloid deposits in the systemic organs, including the heart, lungs, liver, thyroid, and kidney. Immunohistochemical staining revealed an immunoglobulin lambda light chain, which can cause the primary form of systemic amyloidosis. The prognosis of patients with systemic amyloidosis is directly associated with cardiac involvement. In this case, amyloid formation was noted in the myocardial interstitium and intramyocardial vascular wall, which caused luminal narrowing, subsequently causing arrhythmia and ischemic heart disease in each tissue, respectively. We present a case of primary systemic amyloidosis with severe cardiac involvement that was diagnosed after a comprehensive postmortem examination.
Abstract
A 78-year-old woman with a medical history of hypertension and diabetes mellitus who underwent surgery for lumbar stenosis died of sudden cardiac arrest two days after the operation. An autopsy was performed; however, the cause of death was not identified macroscopically. Congo red staining detected amyloid deposits in the systemic organs, including the heart, lungs, liver, thyroid, and kidney. Immunohistochemical staining revealed an immunoglobulin lambda light chain, which can cause the primary form of systemic amyloidosis. The prognosis of patients with systemic amyloidosis is directly associated with cardiac involvement. In this case, amyloid formation was noted in the myocardial interstitium and intramyocardial vascular wall, which caused luminal narrowing, subsequently causing arrhythmia and ischemic heart disease in each tissue, respectively. We present a case of primary systemic amyloidosis with severe cardiac involvement that was diagnosed after a comprehensive postmortem examination.
참고문헌 (23)
- Mitchell RN, "Robbins and Cotran pathologic basis of disease", pp.527~582 (2021), Elsevier
- 박지혜, "2017년도 법의부검에 대한 통계적 고찰", 대한법의학회지, 42(4), pp.111~125 (2018), 대한법의학회[DOI]
- Tambuzzi S, "Lethal cardiac amyloidosis : microscopic differential diagnosis with microfibrillar cardiomyopathy in a forensic case", J Forensic Leg Med, 71, pp.101939~ (2020)
- Quarta CC, "Cardiac amyloidosis", Circulation, 126, pp.e178~e182 (2012)
- Maleszewski JJ, "Cardiac amyloidosis: pathology, nomenclature, and typing", Cardiovasc Pathol, 24, pp.343~350 (2015)
- Musetti V, "Tissue characterization in cardiac amyloidosis", Biomedicines, 10, pp.3054~ (2022)
- D'Errico S, "Sudden death in lambda light chain AL cardiac amyloidosis : a review of literature and update for clinicians and pathologists", Int J Clin Exp Pathol, 13, pp.1474~1482 (2020)
- Kumar V, "Robbins and Cotran pathologic basis of disease", pp.189~266 (2021), Elsevier
- Stelmach-Goldys A, "Physiology, diagnosis and treatment of cardiac light chain amyloidosis", J Clin Med, 11, pp.911~ (2022)
- Vora M, "Contribution of human smooth muscle cells to amyloid angiopathy in AL(light-chain)amyloidosis", Ultrastruct Pathol, 41, pp.358~368 (2017)
- 강구현, "A Case of a Senile Systemic Amyloidosis Patient Presenting With Angina Pectoris and Dilated Cardiomyopathy", Korean Circulation Journal, 41(4), pp.209~212 (2011), 대한심장학회
- Mueller PS, "Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis", Am J Med, 109, pp.181~188 (2000)
- Ogawa H, "Cardiac amyloidosis presenting as microvascular angina : a case report", Angiology, 52, pp.273~278 (2001)
- Bennani Smires Y, "Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction : the high prevalence of amyloid cardiomyopathy", Int J Cardiovasc Imaging, 32, pp.1403~1413 (2016)
- Kim D, "Untangling amyloidosis: recent advances in cardiac amyloidosis", Int J Heart Fail, 2, pp.231~239 (2020)
- Gertz MA, "Immunoglobulin light chain amyloidosis: 2022update on diagnosis, prognosis, and treatment", Am J Hematol, 97, pp.818~829 (2022)
- Glenner GG, "Amyloidosis: its nature and pathogenesis", Semin Hematol, 10, pp.65~86 (1973)
- Palladini G, "How I treat AL amyloidosis", Blood, 139, pp.2918~2930 (2022)
- Vaxman I, "Recent advances in the diagnosis, risk stratification, and management of systemic light-chain amyloidosis", Acta Haematol, 141, pp.93~106 (2019)
- Falk RH, "The systemic amyloidoses", N Engl J Med, 337, pp.898~909 (1997)
- Guan J, "Current perspectives on cardiac amyloidosis", Am J Physiol Heart Circ Physiol, 302, pp.H544~H552 (2012)
- Morin J, "Sudden death due to undiagnosed primary amyloidosis", J Forensic Sci, 58(Suppl 1), pp.S250~S252 (2013)
- De-Giorgio F, "Does the principle of cost", benefit analysis apply to forensic pathology?, 2010, pp.31, 300~